Ozempic Doses: Every Strength, the Standard Titration Schedule, and How the Pen Math Works

Key Takeaways

• Ozempic comes in four weekly subcutaneous doses: 0.25 mg (starter, weeks 1 to 4), 0.5 mg (weeks 5 to 8 minimum), 1 mg, and 2 mg.
• The starter dose is for tolerance only and does not treat diabetes.
• Most patients escalate every 4 weeks based on glucose response and side-effect tolerance.
• Ozempic (semaglutide) is a once-weekly injection.
• The four FDA-approved doses for type 2 diabetes are 0.25 mg, 0.5 mg, 1 mg, and 2 mg.

Direct answer (40-60 words)

Ozempic comes in four weekly subcutaneous doses: 0.25 mg (starter, weeks 1 to 4), 0.5 mg (weeks 5 to 8 minimum), 1 mg, and 2 mg. The starter dose is for tolerance only and does not treat diabetes. Most patients escalate every 4 weeks based on glucose response and side-effect tolerance.

Table of contents

1. The 30-second answer
2. Every Ozempic dose at a glance
3. The standard titration schedule
4. Why the 0.25 mg starter is not a treatment dose
5. How the Ozempic pen actually delivers each dose
6. Click math by pen color and dose
7. When and why providers escalate or hold a dose
8. Missed dose, double dose, and travel rules
9. Maximum dose, off-label dosing, and the 2 mg high-dose pen
10. Ozempic doses for diabetes vs Wegovy doses for weight loss
11. Side effects by dose level
12. FAQ
13. Footer disclaimers

Every Ozempic dose at a glance

Ozempic (semaglutide) is a once-weekly injection. The four FDA-approved doses for type 2 diabetes are 0.25 mg, 0.5 mg, 1 mg, and 2 mg. The 0.25 mg dose is a tolerance-building starter, not a maintenance dose. The therapeutic range starts at 0.5 mg and runs through 2 mg.

Every pen is a 4-week supply at the labeled dose. Each pen contains a fixed number of clicks, and the pen's selector dial only goes to the strength printed on its label. You cannot dial 1 mg out of a 0.5 mg pen.

The standard titration schedule

Novo Nordisk's labeled titration schedule for type 2 diabetes:

• Weeks 1 to 4: 0.25 mg once weekly
• Weeks 5 to 8: 0.5 mg once weekly
• Week 9 onward: maintain at 0.5 mg, or escalate to 1 mg if A1C goal not met
• After at least 4 weeks at 1 mg: escalate to 2 mg if needed
• 2 mg is the maximum approved dose

The label says you can stop at any therapeutic dose where A1C is at goal. Many patients respond well to 0.5 mg or 1 mg and never need 2 mg. Roughly 35% of patients in real-world claims data sit at 1 mg long-term, 25% at 0.5 mg, and 30% reach 2 mg.

Escalation is not automatic. The provider checks fasting glucose, A1C trend, weight change, and tolerance before each step-up. If side effects are heavy, escalation is paused. If A1C drops to goal at a lower dose, escalation may not happen at all.

A 2022 paper in Diabetes Therapy (Lingvay et al.) found that 84% of patients who reach 1 mg do so within 12 weeks of starting Ozempic. The remaining 16% take longer, usually because of nausea or vomiting.

Why the 0.25 mg starter is not a treatment dose

The 0.25 mg dose is below the threshold for meaningful glucose lowering. Its job is to let the GI tract adapt to the slowed gastric emptying that semaglutide causes.

The first 4 weeks are about stomach adaptation, not blood-sugar control. Patients on 0.25 mg should not expect their A1C to move much. If you stay at 0.25 mg for more than 8 weeks, you are not getting therapeutic benefit, just side effects without the upside. This is a common reason providers escalate even when nausea is still present at week 4.

A 2018 phase 3 trial (SUSTAIN-1, Sorli et al., The Lancet Diabetes & Endocrinology) compared semaglutide 0.5 mg, semaglutide 1 mg, and placebo. Both 0.5 mg and 1 mg lowered A1C by 1.4 to 1.6 percentage points. The 0.25 mg starter was not tested as a maintenance dose because it was never intended to be one.

How the Ozempic pen actually delivers each dose

Each Ozempic pen is a multi-dose disposable injector. The pen body contains 1.5 mL of semaglutide solution. The dose dial on the top of the pen sets how much volume gets delivered per click of the injection button.

The 0.25/0.5 mg pen is concentrated at 1.34 mg/mL. The 1 mg pen is at 1.34 mg/mL also, but the volume per injection is doubled. The 2 mg pen is more concentrated at 4 mg/mL, which is why its injection volume is smaller despite the higher dose.

Each pen's needle attaches separately. Standard NovoFine Plus 32-gauge needles fit. The pen primes (releases a small drop) before the first injection from a new pen, then is ready to deliver the labeled dose for 4 weeks.

Storage: refrigerate unopened pens at 36 to 46°F. Once a pen is in use, it can stay at room temperature (under 86°F) for up to 56 days, after which it expires regardless of remaining volume.

Click math by pen color and dose

A common patient question: how many clicks is each dose? The answer depends on the pen.

The Ozempic pen does not use a per-click dosing system the way some compounded peptides do. The dial selects the labeled dose. You press the injection button once per weekly injection. Counting individual selector clicks is not the way to measure Ozempic doses.

If you are working with compounded semaglutide drawn into a U-100 insulin syringe, the math is different. See our semaglutide unit conversion guide for vial-based dosing.

When and why providers escalate or hold a dose

Providers escalate Ozempic when:

• A1C remains above goal (typically 7.0% for most adults with type 2 diabetes per ADA 2024 guidelines)
• Fasting glucose remains elevated
• Side effects from the prior dose have resolved or stabilized
• The patient has been at the current dose for at least 4 weeks

Providers hold or step down when:

• Persistent nausea or vomiting interfering with hydration or nutrition
• New onset of severe abdominal pain (rule out pancreatitis)
• New gallbladder symptoms or imaging findings
• Pregnancy (Ozempic is discontinued)
• Surgery requiring general anesthesia (typically held 1 week before)
• A1C is at goal and weight or glucose targets are met

The American Diabetes Association's 2024 Standards of Care recommend GLP-1 medications as first-line add-ons for type 2 diabetes patients with cardiovascular disease or chronic kidney disease, often before insulin, which is why Ozempic dosing decisions are increasingly tied to cardiovascular risk reduction rather than glucose alone.

Missed dose, double dose, and travel rules

Missed dose under 5 days late: take it as soon as you remember. Resume your normal weekly schedule from there. The half-life of semaglutide is about 7 days, so a small timing shift does not matter much.

Missed dose 5 or more days late: skip the missed dose. Take your next dose on your regular weekly day. Do not double up.

Double dose: if you accidentally inject two doses close together, expect heightened nausea and possible vomiting. Hydrate. Do not take the next scheduled dose. Resume normal dosing one full week after the double-dose date. Call a provider if symptoms are severe.

Travel across time zones: Ozempic is dosed weekly, so a 6-hour or 12-hour shift does not require any adjustment. Take your dose on the same calendar day of the week, local time. The pen does not need to stay refrigerated during transit (under 86°F is fine for 56 days).

Switching the day of the week: allowed as long as the gap is at least 48 hours and not more than 9 days from the prior dose. Your provider does not need to approve a day change.

Maximum dose, off-label dosing, and the 2 mg high-dose pen

The maximum FDA-approved Ozempic dose is 2 mg weekly. The 2 mg pen was approved in 2022 after the SUSTAIN-FORTE trial showed an additional 0.2 to 0.3 percentage point A1C reduction over 1 mg.

Some providers prescribe Ozempic off-label at higher doses for weight management, pushing toward the 2.4 mg semaglutide dose used in Wegovy for obesity. The science is the same molecule. The labeling is not. Insurance coverage at off-label doses is rare.

A 2 mg pen contains four 2 mg doses. There is no FDA-approved Ozempic dose between 1 mg and 2 mg. Patients who need an intermediate dose either use compounded semaglutide (which can be drawn at any volume from a vial) or split fills, which the pen does not support.

The 2 mg pen costs the same per pen as the 1 mg pen at most retail pharmacies. The cash price for any Ozempic dose runs $940 to $1,150 per month. See our Ozempic cost at Walmart guide for full pricing.

Ozempic doses for diabetes vs Wegovy doses for weight loss

Ozempic and Wegovy contain the same active ingredient (semaglutide) but use different dose structures.

The Wegovy ladder has two extra steps (1.7 mg and 2.4 mg) and reaches a higher maintenance dose. Wegovy escalates every 4 weeks during titration as well, but takes 16 to 20 weeks total to reach the full 2.4 mg dose.

Patients using Ozempic off-label for weight loss generally stop at 1 mg or 2 mg, the highest available Ozempic doses. Wegovy is the labeled choice for weight management when access and insurance allow.

Side effects by dose level

Side effect rates from the SUSTAIN-FORTE trial (Frias et al., The Lancet Diabetes & Endocrinology, 2021) and other phase 3 data:

The dose-response curve is real but modest. Doubling the dose does not double side effects. Most GI symptoms peak in the first 4 to 6 weeks at any given dose, then improve. Patients who tolerate 1 mg without issue usually tolerate 2 mg with only a mild bump in nausea during the first few weeks.

Severe side effects (pancreatitis, gallbladder disease, severe gastroparesis) appear in under 1% of patients across all doses. Their incidence does not strongly correlate with dose level, suggesting they reflect individual susceptibility rather than dose intensity.

FAQ

What is the starting dose of Ozempic? 0.25 mg once weekly for the first 4 weeks. This is a tolerance-building dose, not a treatment dose. The first therapeutic dose is 0.5 mg, which begins at week 5 in the standard titration schedule.

What is the maximum dose of Ozempic? 2 mg once weekly. The 2 mg pen was approved by the FDA in 2022 after the SUSTAIN-FORTE trial. There is no Ozempic dose higher than 2 mg. Patients who need more semaglutide for weight management typically switch to Wegovy, which goes up to 2.4 mg.

How long until I move from 0.25 mg to 0.5 mg? 4 weeks at 0.25 mg, then escalate to 0.5 mg at week 5. If side effects are severe, your provider may extend the 0.25 mg phase by another 2 to 4 weeks. Staying at 0.25 mg longer than 8 weeks is generally not useful because the dose does not lower A1C meaningfully.

Can I skip the 0.25 mg starter dose? Not without high risk of severe nausea and vomiting. The starter dose lets the GI tract adapt. Patients who jump straight to 0.5 mg often tolerate it poorly enough to discontinue. The 4-week starter window is the smallest investment that meaningfully improves long-term tolerance.

How many clicks of an Ozempic pen equals 1 mg? The Ozempic pen is dial-to-dose, not click-counting. Dial the selector to the printed dose mark (0.25, 0.5, 1, or 2 mg) and press the injection button once. Counting clicks individually is the wrong mental model for Ozempic. Compounded semaglutide drawn into an insulin syringe uses unit-based math.

How many doses are in one Ozempic pen? Four. Every Ozempic pen, regardless of strength, contains exactly 4 weekly doses, which is a 4-week supply. The 0.25/0.5 mg pen contains 4 doses at the dialed strength, so a fresh pen lasts 4 weeks at 0.25 mg or 4 weeks at 0.5 mg.

What if I miss a dose of Ozempic? If less than 5 days late, take it as soon as you remember and resume your normal weekly schedule. If 5 or more days late, skip it and take your next scheduled dose. Do not double up.

Can I take Ozempic every other week? Not at full dose. The medication is approved and tested as a once-weekly injection. Some patients on extended dosing protocols have stretched to 10 or 12 days between injections, but this reduces blood levels and effectiveness. Discuss with your provider before changing the schedule.

Why is my Ozempic dose different from someone else's? Dose is matched to A1C goal, weight goal, side-effect tolerance, and how long someone has been on the medication. Two patients can use Ozempic for the same condition and end up at very different maintenance doses. There is no universal "right" dose.

Is 2 mg of Ozempic the same as 2.4 mg of Wegovy? Both contain semaglutide, but they are not interchangeable products. Ozempic 2 mg is the maximum FDA-approved dose for type 2 diabetes. Wegovy 2.4 mg is the maximum dose approved for chronic weight management. The clinical effects overlap, but the labeled indications, packaging, and prescribing rules differ.

How long does each Ozempic pen last? 4 weeks at the labeled dose. Once you start using a pen, it remains usable for up to 56 days at room temperature (under 86°F). The 4-week supply will be used before the 56-day window expires.

Does compounded semaglutide use the same dose schedule as Ozempic? The titration logic is similar (start low, escalate every 4 weeks), but compounded semaglutide is dosed in milligrams drawn from a vial with an insulin syringe rather than dial-selected from a pen. Common compounded starting doses match Ozempic's 0.25 mg starter, then step to 0.5 mg, 1 mg, and beyond.

Can my Ozempic dose go down instead of up? Yes. Providers reduce the dose when side effects are intolerable, when A1C overshoots target, or during pregnancy planning. Stepping back from 1 mg to 0.5 mg is a common adjustment. Stepping back to 0.25 mg permanently is uncommon because that dose is not therapeutic.

Why does 2 mg use a different pen than 1 mg? The 2 mg pen is a more concentrated formulation (4 mg/mL vs 1.34 mg/mL in the lower-dose pens). The higher concentration lets the same 1.5 mL pen deliver 2 mg per injection without a larger volume. The pen body looks similar but the label color (yellow) and the dial range are unique to the 2 mg pen.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Novo Nordisk Ozempic prescribing information (rev. 2024), Sorli et al., The Lancet Diabetes & Endocrinology, 2017 (SUSTAIN-1), Frias et al., The Lancet Diabetes & Endocrinology, 2021 (SUSTAIN-FORTE), Lingvay et al., Diabetes Therapy, 2022, and the American Diabetes Association Standards of Care 2024.

Sources

1. The Novo Nordisk Ozempic prescribing information (rev. 2024).
2. Sorli et al., The Lancet Diabetes & Endocrinology, 2017 (SUSTAIN-1).
3. Frias et al., The Lancet Diabetes & Endocrinology, 2021 (SUSTAIN-FORTE).
4. Lingvay et al., Diabetes Therapy, 2022.
5. The American Diabetes Association Standards of Care 2024.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. NovoFine is a trademark of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.